Morgan Stanley (MS)
174.89
+1.17 (0.67%)
NYSE · Last Trade: Dec 5th, 12:36 AM EST
Detailed Quote
| Previous Close | 173.72 |
|---|---|
| Open | 174.32 |
| Bid | 174.50 |
| Ask | 176.00 |
| Day's Range | 173.72 - 176.00 |
| 52 Week Range | 94.33 - 176.00 |
| Volume | 4,813,162 |
| Market Cap | 319.10B |
| PE Ratio (TTM) | 17.94 |
| EPS (TTM) | 9.8 |
| Dividend & Yield | 4.000 (2.29%) |
| 1 Month Average Volume | 5,552,215 |
Chart
About Morgan Stanley (MS)
Morgan Stanley is a leading global financial services firm that provides a wide range of services in investment banking, securities, wealth management, and investment management. Catering to a diverse clientele that includes corporations, governments, and individuals, Morgan Stanley offers expert advisory and financing services, helping clients navigate complex financial markets and achieve their financial objectives. The firm is known for its strategic insights, innovative solutions, and commitment to delivering exceptional service, positioning itself as a trusted partner in the world of finance. Read More
News & Press Releases
Shares of memory chips maker Micron (NYSE:MU)
fell 3.3% in the afternoon session after the company announced its decision to exit the crucial consumer memory business to focus on more strategic growth areas. This move involved shutting down its well-known "Crucial" brand, which sold products like RAM and SSDs. The company stated it would redirect resources toward the rapidly growing demand for advanced memory chips used in artificial intelligence (AI) and data centers. While the company planned to continue shipping consumer products until early 2026 to ensure a smooth transition, the announcement marked a significant shift in its business focus. The stock's drop suggested investor concern regarding the strategic change.
Via StockStory · December 4, 2025
As of early December 2025, the U.S. stock market finds itself in a precarious yet optimistic position, with both the Dow Jones Industrial Average and the S&P 500 index hovering tantalizingly close to their all-time record highs. This remarkable resilience in equity valuations comes amidst a period of
Via MarketMinute · December 4, 2025
Popular equity benchmarks may stop incorporating MSTR stock. Such a decision could weigh meaningfully on the shares.
Via Barchart.com · December 4, 2025
The cryptocurrency market has once again been shaken by a significant price correction in Bitcoin (BTC), with the digital asset experiencing a sharp decline in November and early December 2025. This latest downturn, which saw Bitcoin plummet from an October peak of approximately $125,000-$126,000 to lows around
Via MarketMinute · December 4, 2025
Morgan Stanley Investment Management and MorningStar Senior Living (MorningStar) announced today that investment funds managed by Morgan Stanley Real Estate Investing (MSREI) have acquired a MorningStar senior housing portfolio from Kayne Anderson Real Estate for $305 million. The portfolio is comprised of 463 units across three communities near Denver. MorningStar, a leading senior housing operator based in Denver, will continue to operate the communities.
By Morgan Stanley Investment Management · Via Business Wire · December 4, 2025
The stocks in this article are all trading near their 52-week highs.
This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
Via StockStory · December 3, 2025
Shares of cosmetics company e.l.f. Beauty (NYSE:ELF)
jumped 6.2% in the afternoon session after the company presented at the Morgan Stanley Global Consumer & Retail Conference. Such investor conferences are important events where company leaders often share updates on their business strategy, financial performance, and future outlook. A positive presentation can increase investor confidence and drive interest in a company's stock. The significant upward move in the share price suggested that the market reacted favorably to the information and commentary provided by e.l.f. Beauty's management team during the event.
Via StockStory · December 3, 2025
Shares of toy manufacturing and entertainment company (NASDAQ:MAT)
jumped 4.8% in the afternoon session after the company presented at the Morgan Stanley Global Consumer & Retail Conference, where its leadership shared business updates.
Via StockStory · December 3, 2025
Shares of material handling equipment manufacturer Columbus McKinnon (NASDAQ:CMCO)
jumped 3.4% in the afternoon session after the company presented at a Bank of America conference, highlighting its strong market position and growth prospects. The presentation detailed the company's expansion into high-growth areas like automation and linear motion. Columbus McKinnon pointed to a total addressable market of $34 billion. Management also noted that its growth was supported by major industry trends, including labor shortages and electrification. These factors are driving demand for the company's lifting and automation solutions, which help customers handle critical materials. The positive outlook likely boosted investor confidence.
Via StockStory · December 3, 2025
Shares of diagnostics company Guardant Health (NASDAQ:GH)
jumped 1.8% in the afternoon session after Morgan Stanley raised its price target on the stock, reflecting heightened optimism about the company's potential. The firm's analyst, Shannon O’Callaghan, maintained an "Overweight" rating on Guardant Health while increasing the price target to $130.00 from $105.00. This action followed other positive price target adjustments from analysts in the recent past. Specifically, both BTIG and Canaccord Genuity also previously increased their price targets for the company. These collective revisions signaled a growing positive view of the stock among financial analysts.
Via StockStory · December 3, 2025
Shares of building products company Quanex (NYSE:NX)
jumped 3.8% in the afternoon session after positive technical signals and investor optimism about future earnings growth outweighed mixed historical data.
Via StockStory · December 3, 2025
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM)
jumped 4.5% in the afternoon session after an analyst at Morgan Stanley raised the firm's price target for the stock. The firm's analyst, Patrick Wood, kept an 'Equal-Weight' rating on Tandem Diabetes Care but increased the price target by over 35%, moving it from $17.00 to $23.00. This adjustment suggested a more positive outlook on the stock's value, even while the overall rating remained neutral. The action indicated that the analyst saw more potential upside for the company's shares than previously estimated.
Via StockStory · December 3, 2025
Shares of energy drink company Celsius (NASDAQ:CELH)
jumped 3.6% in the afternoon session after the company provided a positive business update ahead of a conference, highlighting strong market share growth and progress on integrating its Alani Nu brand with its PepsiCo distribution partner.
Via StockStory · December 3, 2025
Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX)
jumped 6.2% in the afternoon session after Morgan Stanley upgraded its rating on the stock to "Overweight" from "Equal-Weight" and increased its price target. The new price target was set at $516, a notable increase from the previous $438. The upgrade reflected the bank's more positive outlook on the potential within Vertex's kidney drug pipeline. The firm specifically highlighted two drug candidates, Pove and Inaxaplin, as key drivers for this optimism. This positive view was formed ahead of the expected release of Phase 3 clinical trial data for these drugs in 2026, suggesting strong confidence in the company's future prospects.
Via StockStory · December 3, 2025
Shares of battery and lighting company Energizer (NYSE:ENR)
jumped 7.6% in the afternoon session after the stock appeared to rebound from a 52-week low set in the prior session, a drop that followed several analyst price target cuts.
Via StockStory · December 3, 2025
New York, NY – December 3, 2025 – In a significant move reverberating through the biotechnology sector, investment banking giant Morgan Stanley has downgraded Regeneron Pharmaceuticals (NASDAQ: REGN) from "Overweight" to "Equal-Weight." The firm maintained its price target of $767.00, signaling that, in their view, the stock is now fairly valued
Via MarketMinute · December 3, 2025
NEW YORK, NY – December 3, 2025 – Morgan Stanley (NYSE: MS) has today achieved a significant milestone, with its stock price reaching an all-time high of $171.78. This landmark achievement underscores the financial services giant's exceptional performance and robust strategic positioning in a dynamic global market. The surge reflects strong
Via MarketMinute · December 3, 2025
Valued at a market cap of $1.8 trillion, Broadcom is a mega-cap chip stock that offers significant upside potential, according to Morgan Stanley.
Via Barchart.com · December 3, 2025
Nvidia stock is at the epicenter of the AI gold rush and has significant upside potential in December 2025, according to Morgan Stanley.
Via Barchart.com · December 3, 2025
In a significant move that has captured the attention of financial markets, Deutsche Bank (DB) (NYSE:DB) has issued an exceptionally bullish forecast for the S&P 500 (SPX) (NYSEARCA:SPY), setting a year-end target of 8,000 for 2026. This ambitious prediction positions Deutsche Bank's outlook as one of
Via MarketMinute · December 3, 2025
Shares of analog chips maker onsemi (NASDAQ:ON)
jumped 7.1% in the morning session after the company announced plans to collaborate with Innoscience to speed up the global rollout of its Gallium Nitride (GaN) power portfolio.
Via StockStory · December 3, 2025
Check out the companies making headlines yesterday:
Via StockStory · December 3, 2025
Both AI giants might launch their public market offerings next year.
Via Stocktwits · December 3, 2025
Despite AutoZone’s recent underperformance relative to the Nasdaq, analysts remain highly optimistic about the stock’s prospects.
Via Barchart.com · December 3, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Charles Schwab (NYSE:SCHW) and its peers.
Via StockStory · December 2, 2025
